Meilahden tornisairaala on HYKS-sairaanhoitoalueeseen kuuluva sairaala. Sairaalan nimi vaihdettiin vuonna 2010 jotta sairaala erottuisi alueen monista muista HUS-sairaaloista. Sairaala sijaitsee Helsingissä Meilahden kaupunginosassa, ja sen katuosoite on Haartmaninkatu 4.

During the past decade, Helsingin yliopistollinen keskussairaala, Meilahden sairaala conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are "Prostate Cancer" (2 trials), "Cancer of the Prostate" (1 trials), "Hemophilia A" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" in a lesser frequency.

Most popular intervention types in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Abiraterone" (1 trials), "Emicizumab" (1 trials), "Placebo" (1 trials) and "Placebo for Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Helsingin yliopistollinen keskussairaala, Meilahden sairaala". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Helsingin yliopistollinen keskussairaala, Meilahden sairaala, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helsingin yliopistollinen keskussairaala, Meilahden sairaala, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".